The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Rizatriptan reduces vestibular-induced motion sickness in migraineurs
Open accessAbstract
A previous pilot study suggested that rizatriptan reduces motion sickness induced by complex vestibular stimulation. In this double-blind, randomized, placebo-controlled study we measured motion sickness in response to a complex vestibular stimulus following pretreatment with either rizatriptan or a placebo. Subjects included 25 migraineurs with or without migraine-related dizziness (23 females) aged 21-45 years (31.0 ± 7.8 years). Motion sickness was induced by off-vertical axis rotation in darkness, which stimulates both the semicircular canals and otolith organs of the vestibular apparatus. Results indicated that of the 15 subjects who experienced vestibular-induced motion sickness when pretreated with placebo, 13 showed a decrease in motion sickness following pretreatment with rizatriptan as compared to pretreatment with placebo (P < 0.02). This significant effect was not seen when subjects were exposed to more provocative vestibular stimulation. We conclude that the serotonin agonist, rizatriptan, reduces vestibular-induced motion sickness by influencing serotonergic vestibular-autonomic projections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, two double-blind, placebo-controlled studies showed that 5-HT 1B/1D receptor agonist rizatriptan prevented the development of MS in migrainous patients [103,104].”
From Motion Sickness: Current Knowledge and Recent Advance. (2016) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · Applied Ergonomics · doi:10.1016/0003-6870(92)90318-p · Cited by 5,737
The International Classification of Headache Disorders: 2nd edition
Olesen, J., Goadsby, P., & Steiner, T. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00590-8 · Cited by 5,049
The practice of behavior therapy
Wolpe, J. (1969) · Cited by 2,343
The International Classification of Headache Disorders
Olesen, J. (2008) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01121.x · Cited by 2,321
Olesen, J. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2003.00824.x · Cited by 2,056
The interrelations of migraine, vertigo, and migrainous vertigo
Neuhauser, H., Leopold, M., von Brevern, M., Arnold, G., & Lempert, T. (2001) · Neurology · doi:10.1212/wnl.56.4.436 · Cited by 792 · cited 1×
“This study was designed to evaluate 25 subjects with migraine with or without an additional diagnosis of migraine-related dizziness [11, 12].”
BackgroundNEURO-OTOLOGICAL MANIFESTATIONS OF MIGRAINE
KAYAN, A., & HOOD, J. D. (1984) · Brain · doi:10.1093/brain/107.4.1123 · Cited by 533 · cited 1×
“It is also notable that motion sickness occurs in approximately 50% of patients with migraine [4].”
BackgroundA PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate
Afridi, S. K. (2005) · Brain · doi:10.1093/brain/awh416 · Cited by 453
Migrainous vertigo: Prevalence and impact on quality of life
Neuhauser, H. K., Radtke, A., von Brevern, M., Feldmann, M., Lezius, F., Ziese, T., & Lempert, T. (2006) · Neurology · doi:10.1212/01.wnl.0000237539.09942.06 · Cited by 451
(1968) · PubMed · Cited by 428
Cited by
Vestibular migraine: the most frequent entity of episodic vertigo
Dieterich, M., Obermann, M., & Celebisoy, N. (2016) · Journal of Neurology · doi:10.1007/s00415-015-7905-2 · Cited by 307
“Two of these studies addressed the use of triptans for attack therapy [69, 70].”
BackgroundVestibular migraine: clinical aspects and pathophysiology
Furman, J. M., Marcus, D. A., & Balaban, C. D. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70107-8 · Cited by 284
Self-citationMotion Sickness: Current Knowledge and Recent Advance.
Zhang, L., Wang, J., Qi, R., Pan, L., Li, M., & Cai, Y. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12468 · Cited by 216
“Additionally, two double-blind, placebo-controlled studies showed that 5-HT1B/1D receptor agonist rizatriptan prevented the development of MS in migrainous patients [103,104].”
BackgroundBalaban, C. D., Jacob, R. G., & Furman, J. M. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.19 · Cited by 214
Self-citationVestibular migraine: An update on current understanding and future directions
Huang, T.-C., Wang, S.-J., & Kheradmand, A. (2020) · Cephalalgia · doi:10.1177/0333102419869317 · Cited by 167
Metadata
- Authors
- Furman, J. M., Marcus, D. A., & Balaban, C. D.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Furman, Joseph M.
- ORCID
- Balaban, Carey D.
- Venue
- The Journal of Headache and Pain
- Published
- 2010-09-23
- Volume
- 12
- Issue
- 1
- Pages
- 81-88
- ISSN
- 1129-2369 (ISSN-L)
- 1129-2377
- PMC
- PMC3072502
- OpenAlex
- W2126488507
- Cited by
- 82
- References
- 48
- Citations by year
- 2025: 4 · 2024: 7 · 2023: 4 · 2022: 9 · 2021: 7 · 2020: 11 · 2019: 5 · 2018: 2 · 2017: 6 · 2016: 10 · 2015: 4 · 2014: 5 · 2013: 3 · 2012: 2
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/2.0 (tdm)
- creativecommons.org/licenses/by-nc/2.0 (vor)
- Locations
- The Journal of Headache and Pain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Deafness and Other Communication Disorders (R01DC000739)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Keywords
- rizatriptan, migraine, off-vertical axis rotation, semicircular canals, otolith organs, serotonin receptor agonists, vestibular stimulation
- MeSH terms
- Adult, Double-Blind Method, Female, Humans, Male, Middle Aged, Migraine Disorders, Motion Sickness, Triazoles, Tryptamines, Vestibular Diseases, Treatment Outcome, Serotonin Receptor Agonists, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rizatriptan reduces vestibular-induced motion sickness in migraineurs. https://app.cochat.ai/papers/10.1007/s10194-010-0250-z
- The paper
- Furman, J. M., Marcus, D. A., & Balaban, C. D. (2011). Rizatriptan reduces vestibular-induced motion sickness in migraineurs. The Journal of Headache and Pain. https://doi.org/10.1007/s10194-010-0250-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.